Leukemia Clinical Trials

Showing 3341-3360 of 10,987 trials

Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients

NCT06746571

Role of cbc indices in acute lymphoblastic leukemia patients to explore the prognostic role of them in prediction the response to induction chemotherapy

Lymphoblastic Leukemia

Sohag University100 participantsStarted Jan 2025

Sohag, Egypt

Enrolling By InvitationEARLY Phase 1

INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer

NCT06747832

This is a clinical study on the use of iNK cells for the treatment of small cell lung cancer.

Small Cell Lung Cancer

Guangzhou Ruixin Biotechnological Co., LTD10 participantsStarted Dec 2024

Weifang, Shandong Province, China., China

Active Not RecruitingNA

Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair

NCT05142618

This study aims to evaluate the potential role of physical therapy in improving outcomes after ventral hernia repair.

Ventral HerniaHerniaHerniorrhaphy+3 more

Ohio State University138 participantsStarted Apr 2022

Columbus, Ohio, United States

COMPLETEDPhase 1/2

Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

NCT03043599

The purpose of the safety run in Phase I portion of this study is to confirm the recommended Phase II dose of ipilimumab and nivolumab among participants treated with combined thoracic radiation therapy (30 Gy in 10 fractions) and nivolumab/ipilimumab following standard treatment with 4-6 cycles of platinum-based chemotherapy. The purpose of the Phase II portion of this study is to estimate the 6-month Progression Free Survival (PFS) rate among participants treated with ipilimumab and nivolumab with thoracic radiation therapy (30 Gy in 10 fractions) after standard treatment with 4 to 6 cycles of platinum based chemotherapy.

Small Cell Lung CancerExtensive-stage Small Cell Lung Cancer

H. Lee Moffitt Cancer Center and Research Institute21 participantsStarted Feb 2017

Tampa, Florida, United States

Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients

INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer

Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair

Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Related Searches

Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India

Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer

GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases

Virtual Reality Fall Education for Caregivers

FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC

Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study

Phase I/II Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer

The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population

VHAG in Treating R/R T-ALL/LBL

A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil

A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS

Microbial Study of Sublingual Immunotherapy Tablets in Patients With Allergic Rhinitis

Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC

PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1